Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant: genes and variants
Explore variant evidence for Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant across 1 analyzed protein (GRIN1). Linked ClinVar records include 55 pathogenic or likely pathogenic variants, 179 variants of uncertain significance and 42 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant
GRIN1: Glutamate receptor ionotropic, NMDA 1
It provides an obligatory subunit of NMDA receptors and is essential for glutamate-dependent synaptic transmission, calcium signaling, and plasticity. Pathogenic variants can cause GRIN1-related neurodevelopmental disorder with intellectual disability, movement abnormalities, epilepsy, and cortical visual impairment.
55 ClinVar pathogenic / likely pathogenic and 221 uncertain variants in GRIN1 have source records linked to Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant. Association strength is not clinical gene validity.
Where Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant variants cluster
- GRIN1 Transmembrane (positions 628–648): 13 of 54 ClinVar pathogenic / likely pathogenic variants, 10.8× more than its size predicts (a length-based count, not a validated hotspot).
- GRIN1 Transmembrane (positions 812–835): 7 of 54 ClinVar pathogenic / likely pathogenic variants, 5.1× more than its size predicts (a length-based count, not a validated hotspot).
- GRIN1 Cytoplasmic (positions 616–627): 5 of 54 ClinVar pathogenic / likely pathogenic variants, 7.2× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GRIN1 R844C | 844 | Cytoplasmic | Pathogenic / likely pathogenic (★★★★) |
| GRIN1 G618R | 618 | Pore-forming | Pathogenic / likely pathogenic (★★) |
| GRIN1 M641L | 641 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GRIN1 M641V | 641 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GRIN1 R794Q | 794 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GRIN1 P557L | 557 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GRIN1 G620R | 620 | Pore-forming | Pathogenic / likely pathogenic (★★) |
| GRIN1 R659W | 659 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GRIN1 R659Q | 659 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GRIN1 G638A | 638 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GRIN1 M818L | 818 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GRIN1 R844L | 844 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| GRIN1 D227H | 227 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GRIN1 S549R | 549 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GRIN1 G633V | 633 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GRIN1 I643V | 643 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GRIN1 P805L | 805 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GRIN1 G827R | 827 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GRIN1 S688Y | 688 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GRIN1 G618V | 618 | Pore-forming | Pathogenic / likely pathogenic (★) |
| GRIN1 M641T | 641 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GRIN1 M641I | 641 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GRIN1 R794P | 794 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 R794G | 794 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 M818R | 818 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GRIN1 M555I | 555 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 M555T | 555 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 Q556H | 556 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 Q556R | 556 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 N616S | 616 | Pore-forming | Pathogenic / likely pathogenic (★) |
| GRIN1 S617F | 617 | Pore-forming | Pathogenic / likely pathogenic (★) |
| GRIN1 V635G | 635 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GRIN1 A640P | 640 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GRIN1 I642T | 642 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GRIN1 V644A | 644 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GRIN1 A645S | 645 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GRIN1 Y647H | 647 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GRIN1 V656G | 656 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 V793F | 793 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 M813T | 813 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GRIN1 G815R | 815 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GRIN1 V816F | 816 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GRIN1 F817L | 817 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GRIN1 Q405L | 405 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 K483Q | 483 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 N650K | 650 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 C744Y | 744 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 D789N | 789 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 A806E | 806 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 E172K | 172 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 W611L | 611 | Discontinuously helical | Pathogenic / likely pathogenic (★) |
| GRIN1 K531R | 531 | Extracellular | Pathogenic / likely pathogenic (★) |
| GRIN1 E662K | 662 | Extracellular | Pathogenic / likely pathogenic |
| GRIN1 D552E | 552 | Extracellular | Pathogenic / likely pathogenic |
| GRIN1 F654C | 654 | Extracellular | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| GRIN1 R794L | 794 | Extracellular | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; R794P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.82 |
| GRIN1 G815W | 815 | Transmembrane | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; G815R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| GRIN1 S617C | 617 | Pore-forming | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; S617F at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
| GRIN1 A806V | 806 | Extracellular | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; A806E at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.91 |
| GRIN1 G815E | 815 | Transmembrane | Uncertain (★) | +6: 6 other pathogenic changes within 3 positions; G815R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| GRIN1 F654S | 654 | Extracellular | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; F654C at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| GRIN1 I643T | 643 | Transmembrane | Uncertain (★) | +6: 9 other pathogenic changes within 3 positions; I643V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97 |
| GRIN1 G638S | 638 | Transmembrane | Uncertain (★) | +6: 7 other pathogenic changes within 3 positions; G638A at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
Which prediction tools work for Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 87 out of 100
- PolyPhen-2: 81 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 81 out of 100
- REVEL: 75 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 75 out of 100
- CATVariant: 73 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 70 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 67 out of 100
- MetaSVM: 56 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 55 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 51 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 46 out of 100
Diseases related to Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant
- Developmental and epileptic encephalopathy, also linked to GRIN1
- Rolandic epilepsy, also linked to GRIN1
Frequently asked questions
Which genes have records linked to Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant?
This view contains 1 analyzed proteins: GRIN1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 55 pathogenic or likely pathogenic variants, 179 variants of uncertain significance and 42 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 8 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 313 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center